However, the difference between the two groups in the peak levels of LH and FSH during the GnRH test was statistically significant; this result is consistent with the test interpretation and diagnosis of CPP, which requires a peak level of LH higher than 3.3 IU/L. The gene discussed is BRD2; the disease is central precocious puberty.